View Pages
Weekly Market Movers: Meta Chip Plans, Paramount Skydance Scrutiny, Forte Biosciences Rally
Meta’s in-house AI chip lifts suppliers; states may challenge Paramount Skydance–Warner deal; Forte Biosciences jumps after promising vitiligo trial results. Bloomberg roundup of this week’s biggest stock movers.
Editorial companion
What stands out
Meta's decision to press ahead with an in-house AI chip turned into an instant ripple for the semiconductor equipment makers that actually build chips, sending Applied Materials, Lam Research, KLA and optical supplier Lumentum higher and reminding investors how one platform move can reorder a supply chain. Meanwhile Paramount Skydance's proposed $110 billion tie-up faces a potential wave of state challenges, and biotech Forte Biosciences moved violently on positive FB102 data, a neat reminder that headline-driven moves still dominate market microstructure across tech, media and biotech.
View Pages
View Pages
Bullish Gator Snapshot
Current ratings and signals
Applied Materials (AMAT)
Neutral
AMAT rates Neutral overall. The fundamental read is bullish: the company passes 6 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Safe zone (Altman Z = 15.71); revenue is growing about 3.2% per year; net income is growing about 2.4% per year. The technical picture is bearish: price is 10.5% below the 200-day moving average; 14.5% below the 50-day; the 50/200 relationship is in a Golden cross. Sentiment is bullish (composite 72/100), based on 5 news articles from recent coverage.
KLA Corporation (KLAC)
Bearish
KLAC rates Bearish overall. The fundamental read is bullish: the company passes 6 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Safe zone (Altman Z = 12.51); revenue is growing about 9.7% per year; net income is growing about 15.8% per year. The technical picture is bearish: price is 15.4% below the 200-day moving average; 14.8% below the 50-day; the 50/200 relationship is in a Death cross. Sentiment is bearish (composite 48/100), based on 8 news articles from recent coverage.
Lam Research (LRCX)
Neutral
LRCX rates Neutral overall. The fundamental read is bullish: the company passes 8 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Safe zone (Altman Z = 20.81); revenue is growing about 11.7% per year; net income is growing about 20.2% per year. The technical picture is bearish: price is 15.0% below the 200-day moving average; 19.3% below the 50-day; the 50/200 relationship is in a Golden cross. Sentiment is neutral (composite 56/100), based on 7 news articles and 7 qualified videos from recent coverage.